Episode 507: ASCO 2026 - TALAPRO-3

from The Uromigos · host The Uromigos

Neeraj Aggarwal joins the show to discuss the phase 3 TALAPRO-3 trial of talazoparib and enzlautamide in metastatic hormone-sensitive prostate cancer, focusing on trial design, efficacy, safety, and genetic subsets.

Episode metadata supplied by the publisher feed · Published May 30, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Episode 507: ASCO 2026 - TALAPRO-3

0:00 41:45

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Uromigos?

This episode is 41 minutes long.

When was this The Uromigos episode published?

This episode was published on May 30, 2026.

Can I download this The Uromigos episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!